Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Tazarotene

EU orphan designation number: EU/3/06/423
Active ingredient: Tazarotene
Indication: Treatment of congenital ichthyoses
Sponsor: Orfagen
CRDPF Langlade, 3 avenue Hubert Curien, BP 13562, F-31035 Toulouse CEDEX 1, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/12/2006 Orphan Designation EMEA/OD/073/06 (2006)7018 of 18/12/2006
30/05/2011 Change of address of sponsor EMEA/OD/073/06
30/01/2015 Removal of orphan designation from Community Register